EMMESSA logo

Emmessar Biotech & Nutrition Ltd

EMMESSA·BSE·
24.55 +0.25 (+1.03%)
Market Cap12.69 Cr
PE Ratio38.36
Volume6,287
Day High - Low25.99 - 23.08
52W High-Low33.38 - 18.42
DocStoX Score
3.6/10
Poor
Fair Value
Sign in to see
ROE
5.56%
Weak
P/E
38.36x
Expensive
Debt / Equity
0.00
Low
Industry
Chemicals
Commodity Chemicals
Overall View
Poor

Price performance

Day23.08
25.99
52W18.42
33.38
DocStoX take

Supported by risk (7.2), but held back by valuation (1.0).

DocStoX score

Low confidence
3.6
/10
Poor
Quality
Solid
ROE 5.6%
Valuation
Expensive
P/E 38.4×
Growth
Flat
Revenue -44.4% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Soft
41% of 52-week range

At a glance

Market Cap
₹13 Cr
52W High / Low
₹33 / ₹18
Dividend Yield
0.00%
Promoter Holding
59.53%
EPS (TTM)
₹0.64
Book Value
₹16.24

Key highlights

  • Healthy net margin (52%)
  • Low leverage — D/E 0.00
  • Profitable in all of the last 5 years
  • Profit shrinking 23% a year
  • Revenue shrinking 44% a year
3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Chemicals stocks · Commodity Chemicals

Emmessar Biotech & Nutrition Ltd peers in Chemicals

Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.